(Reuters) – The U.S Food and Drug Administration on Wednesday recommended healthcare facilities transition away from using Getinge’s heart devices as they continued to have safety and quality concerns.
(Reporting by Sriparna Roy in Bengaluru; Editing by Shailesh Kuber)
Brought to you by www.srnnews.com
